Research & Development

With its liposomal technology platform, InnoMedica has almost unlimited possibilities to improve existing drugs. The main constraint placed on our researchers are financial limits which imposes a strict prioritization in the pipeline. The team around Dr. Silvia Erni is currently focusing mainly on the two products currently undergoing clinical trials, but also on the most promising pipeline products from the fields of neurology, oncology, infectiology and immunology.

Dr. Šime Brkić – PhD in Vascular Biology, University of Basel; previously: Postdoc in Oncology at the Department of Biomedicine, University Hospital Basel
Dr. Silvia Erni – PhD in Biomedical Sciences, University of Bern
Dr. Marion Kieffer – PhD in Chemistry, University of Cambridge (UK); previously: Research Associate, University of Bristol (UK)
Dr. Henrik Peters – PhD in Chemistry, University of Basel; previously: Research Associate, University of Bern